Division of Immunology, Beckman Research Institute of City of Hope, 1500, East Duarte Road, Duarte, CA 91010, USA.
Curr Opin Pharmacol. 2010 Dec;10(6):775-81. doi: 10.1016/j.coph.2010.09.004.
It has been observed that some ligands cause receptors to selectively interact with subsets of signaling proteins to 'bias' their signaling; this is inconsistent with receptors forming a single active state. Here we review the concept of receptor conformation ensembles that can account for a given agonist showing varied efficacies for different signaling pathways. Data show that agonists can stabilize different receptor conformations. We provide a demonstration at the molecular level of how the various receptor conformations in the ensemble can produce functional selectivity for signaling pathways. Specifically, agonists that selectively stabilize certain receptor conformations from the ensemble can produce biased agonism towards this signaling pathway. These ideas are described with data supported from recent computations of the potential energy surface of the β2-adrenergic receptor.
已经观察到,一些配体导致受体选择性地与信号蛋白的子集相互作用,从而“偏向”它们的信号;这与受体形成单一的活性状态不一致。在这里,我们回顾了受体构象集合的概念,该概念可以解释给定的激动剂对不同信号通路表现出不同的效力。数据表明,激动剂可以稳定不同的受体构象。我们在分子水平上提供了一个演示,说明集合中的各种受体构象如何产生信号通路的功能选择性。具体来说,选择性地稳定来自集合中的某些受体构象的激动剂可以产生对此信号通路的偏向激动作用。这些想法是基于最近对β2-肾上腺素能受体势能面的计算数据来描述的。